Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues

Oncology Reports

Volumn 21, Issue 3, 2009, Pages 713-719

  Wang, Xue Yan ^a,b   Chen, Hong Song ^a   Luo, Su ^b   Zhang, Heng Hui ^a   Fei, Ran ^a   Cai, Jun ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b BEIHUA UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; MRNA expression; NY ESO 1

Indexed keywords

CANCER TESTIS ANTIGEN; DNA POLYMERASE; LAGE 1 ANTIGEN; MESSENGER RNA; NY ESO 1 ANTIGEN; PRIMER DNA; SSX 1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; AGED; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARCINOMA, HEPATOCELLULAR; DNA PRIMERS; DNA-DIRECTED DNA POLYMERASE; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 64849107359     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000276     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Tang ZY, Yu YQ, Zhou XD, Ma ZC and Wu ZQ: Progress and prospects in hepatocellular carcinoma surgery. Ann Chir 52: 558-563, 1998.
3. Tang ZY: Hepatocellular carcinoma - cause, treatment and metastasis. World J Gastroenterol 7: 445-454, 2001.
4. Chen YT, Scanlan MJ, Sahin U, et al: A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94: 1914-1918, 1997.
5. Van der Bruggen P, Traversari C, Chomez P, et al: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647, 1991.
6. Crew AJ, Clark J, Fisher C, et al: Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 14: 2333-2340, 1995.
7. CT Gene database. URL: http://www.cancerimmunity.org/CTdatabase/
8. Scanlan MJ, Simpson AJ and Old LJ: The cancer/testis genes: review, standardization and commentary. Cancer Immun 4: 1, 2004.
9. Sahin U, Tureci O, Chen YT, et al: Expression of multiple cancer/ testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer 78: 387-389, 1998.
10. Scanlan MJ, Altorki NK, Gure AO, et al: Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett 150: 155-164, 2000.
11. Lee SY, Obata Y, Yoshida M, et al: Immunomic analysis of human sarcoma. Proc Natl Acad Sci USA 100: 2651-2656, 2003.
12. Stockert E, Jager E, Chen YT, et al: A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 187: 1349-1354, 1998.
13. Jager E, Chen YT, Drijfhout JW, et al: Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 187: 265-270, 1998.
14. Jager E, Stockert E, Zidianakis Z, et al: Humoral immune responses of cancer patients against 'Cancer-Testis' antigen NY-ESO-1: correlation with clinical events. Int J Cancer 84: 506-510, 1999.
15. Luo G, Huang S, Xie X, et al: Expression of cancer-testis genes in human hepatocellular carcinomas. Cancer Immun 2: 11-15, 2002.
16. Wu L-Q, Wang X-J, Lu Y, et al: Expression of cancer/testis antigens SSX-1and NY-ESO-1 mRNA in hepatocellular carcinoma and its clinical significance. World Chin J Digestol 13: 1673-1678, 2005.
17. Korangy F, Ormandy LA, Bleck JS, et al: Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma. Clin Cancer Res 10: 4332-4341, 2004.
18. Zhang W-M, Xiao G, Xie D, et al: Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma. Chin J Cancer 24: 622-626, 2005.
19. Chen C-H, Chen G-J, Lee H-S, et al: Expressions of cancer-testis antigens in human hepatocellular carcinomas. Cancer Lett 164: 189-195, 2001.
20. Peng J-R, Chen H-S, Mou D-C, et al: Expression of cancer/testis (CT) antigen in Chinese hepatocellular carcinoma and its correlation with clinical parameters. Cancer Lett 219: 223-232, 2005.
21. Sobin LH and Wittekind CH: TNM classification of malignant tumors. 5th edition, Wiley-Liss, New York, pp74-77, 1997.
22. Chen YT, Gure AO, Tsang S, et al: Identification of multiple cancer-testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 95: 6919-6923, 1998.
23. Chen YT, Boyer AD, Viars CS, Tsang S, Old LJ and Arden KC: Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, touman chromosome Xq28. Cytogenet Cell Genet 79: 237-240, 1997.
24. Lethe B, Lucas S, Michaux L, et al: LAGE-1, a new gene with tumor specificity. Int J Cancer 76: 903-908, 1998.
25. Xing BC, Yuan YH, Hu ZG, et al: Expression of NY-ESO-1/LAGE-1 genes in hepatocellular carcinoma and autologous humoral responses induced thereby. Zhonghua Yi Xue Za Zhi 84: 1980-1982, 2004.
26. De Smet C, Lurquin C, Lethe B, Martelange V and Boon T: DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 19: 7327-7335, 1999.